y.c.r. scientific developments limited Company Information
Company Number
04194001
Registered Address
unit a3 hornbeam square west, harrogate, north yorkshire, HG2 8PA
Industry
Other business support service activities n.e.c.
Telephone
01423501269
Next Accounts Due
December 2024
Group Structure
View All
Directors
Robert Langlands1 Years
Shareholders
yorkshire cancer research 100%
y.c.r. scientific developments limited Estimated Valuation
Pomanda estimates the enterprise value of Y.C.R. SCIENTIFIC DEVELOPMENTS LIMITED at £375 based on a Turnover of £927 and 0.4x industry multiple (adjusted for size and gross margin).
y.c.r. scientific developments limited Estimated Valuation
Pomanda estimates the enterprise value of Y.C.R. SCIENTIFIC DEVELOPMENTS LIMITED at £0 based on an EBITDA of £0 and a 3.09x industry multiple (adjusted for size and gross margin).
y.c.r. scientific developments limited Estimated Valuation
Pomanda estimates the enterprise value of Y.C.R. SCIENTIFIC DEVELOPMENTS LIMITED at £513 based on Net Assets of £200 and 2.57x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Y.c.r. Scientific Developments Limited Overview
Y.c.r. Scientific Developments Limited is a live company located in north yorkshire, HG2 8PA with a Companies House number of 04194001. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in April 2001, it's largest shareholder is yorkshire cancer research with a 100% stake. Y.c.r. Scientific Developments Limited is a mature, micro sized company, Pomanda has estimated its turnover at £927 with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Y.c.r. Scientific Developments Limited Health Check
Pomanda's financial health check has awarded Y.C.R. Scientific Developments Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 6 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
6 Weak
Size
annual sales of £927, make it smaller than the average company (£3m)
- Y.c.r. Scientific Developments Limited
£3m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (4%)
- Y.c.r. Scientific Developments Limited
4% - Industry AVG
Production
with a gross margin of 17.4%, this company has a higher cost of product (38.4%)
- Y.c.r. Scientific Developments Limited
38.4% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Y.c.r. Scientific Developments Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (20)
- Y.c.r. Scientific Developments Limited
20 - Industry AVG
Pay Structure
on an average salary of £43.7k, the company has an equivalent pay structure (£43.7k)
- Y.c.r. Scientific Developments Limited
£43.7k - Industry AVG
Efficiency
resulting in sales per employee of £927, this is less efficient (£137.7k)
- Y.c.r. Scientific Developments Limited
£137.7k - Industry AVG
Debtor Days
it gets paid by customers after 78 days, this is later than average (39 days)
- Y.c.r. Scientific Developments Limited
39 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Y.c.r. Scientific Developments Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Y.c.r. Scientific Developments Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Y.c.r. Scientific Developments Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Y.c.r. Scientific Developments Limited
- - Industry AVG
Y.C.R. SCIENTIFIC DEVELOPMENTS LIMITED financials
Y.C.R. Scientific Developments Limited's latest turnover from March 2023 is estimated at £927 and the company has net assets of £200. According to their latest financial statements, we estimate that Y.C.R. Scientific Developments Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | ||||||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
total assets | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
net assets | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
total shareholders funds | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
Tax | ||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
y.c.r. scientific developments limited Credit Report and Business Information
Y.c.r. Scientific Developments Limited Competitor Analysis
Perform a competitor analysis for y.c.r. scientific developments limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in HG2 area or any other competitors across 12 key performance metrics.
y.c.r. scientific developments limited Ownership
Y.C.R. SCIENTIFIC DEVELOPMENTS LIMITED group structure
Y.C.R. Scientific Developments Limited has no subsidiary companies.
Ultimate parent company
1 parent
Y.C.R. SCIENTIFIC DEVELOPMENTS LIMITED
04194001
y.c.r. scientific developments limited directors
Y.C.R. Scientific Developments Limited currently has 1 director, Sir Robert Langlands serving since Dec 2022.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Sir Robert Langlands | England | 72 years | Dec 2022 | - | Director |
P&L
March 2023turnover
927
+4%
operating profit
0
0%
gross margin
17.4%
+5.64%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
200
0%
total assets
200
0%
cash
0
0%
net assets
Total assets minus all liabilities
y.c.r. scientific developments limited company details
company number
04194001
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
April 2001
age
23
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
unit a3 hornbeam square west, harrogate, north yorkshire, HG2 8PA
Bank
-
Legal Advisor
-
y.c.r. scientific developments limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to y.c.r. scientific developments limited.
y.c.r. scientific developments limited Companies House Filings - See Documents
date | description | view/download |
---|